cancer
Institute of Cancer Research embraces olaparib recommendation
Posted in Medicine on 11th Apr, 2023
by Alex Muller
"Olaparib is an important example of how understanding the underlying genetics of patients, and their tumours’ genomics, can be used to design highly targeted precision medicines.”
Cancer: New blood test could catch prostate cancer early
Posted in Medicine on 10th Apr, 2023
by Alex Muller
The project will investigate specific sugars found in the bloodstream of men with prostate cancer that could be used in tests to determine a man's risk of developing the disease, and how likely it is to spread.
Combination Treatment Extends Progression-Free Survival in Brain Cancer
Posted in Medicine, Science on 10th Apr, 2023
by Alex Muller
Overall, average survival time was numerically, but not significantly, longer in the combined treatment group versus the bevacizumab-only group; 10.1 months versus 9.7 months, respectively.
Scientists discover a new way to help prevent breast cancer ‘time bomb’
Posted in Medicine, Science on 6th Apr, 2023
by Alex Muller
Scientists have discovered why breast cancer cells that have spread to the lungs may ‘wake up’ following years of sleep - forming incurable secondary tumours.
NHS approves 'life changing' drug for breast and prostate cancer patients
Posted in Medicine, Science on 6th Apr, 2023
by Alex Muller
Clinical trials have shown that olaparib, also known as Lynparza and manufactured by pharmaceutical firm AstraZeneca, can extend advanced prostate cancer patients’ lives by "an average of six months", NHS England said.